Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$6.47 - $9.57 $12,849 - $19,006
-1,986 Reduced 0.74%
265,087 $2.02 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $44,125 - $66,042
4,892 Added 1.87%
267,073 $2.47 Million
Q3 2021

Oct 27, 2021

BUY
$13.71 - $17.18 $3.59 Million - $4.5 Million
262,181 New
262,181 $3.73 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Jabodon Pt CO Portfolio

Follow Jabodon Pt CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

News

Stay updated on Jabodon Pt CO with notifications on news.